Literature DB >> 11693529

Transthyretin: a review from a structural perspective.

J A Hamilton1, M D Benson.   

Abstract

Transthyretin (formerly called prealbumin) plays important physiological roles as a transporter of thyroxine and retinol-binding protein. X-ray structural studies have provided information on the active conformation of the protein and the site of binding of both ligands. Transthyretin is also one of the precursor proteins commonly found in amyloid deposits. Both wild-type and single-amino-acid-substituted variants have been identified in amyloid deposits, the variants being more amyloidogenic. Sequencing of the gene and the resulting production of a transgenic mouse model have resulted in progress toward solving the mechanism of amyloid formation and detecting the variant gene in individuals at risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11693529     DOI: 10.1007/PL00000791

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  64 in total

Review 1.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Inhibition of curli assembly and Escherichia coli biofilm formation by the human systemic amyloid precursor transthyretin.

Authors:  Neha Jain; Jörgen Ådén; Kanna Nagamatsu; Margery L Evans; Xinyi Li; Brennan McMichael; Magdalena I Ivanova; Fredrik Almqvist; Joel N Buxbaum; Matthew R Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

3.  Transport of maternal transthyretin to the fetus in the viviparous teleost Neoditrema ransonnetii (Perciformes, Embiotocidae).

Authors:  Osamu Nakamura; Rintaro Suzuki; Kotaro Asai; Harunobu Kaji; Takuya Kaneko; Yo Takahashi; Ayaka Takahagi; Shigeyuki Tsutsui
Journal:  J Comp Physiol B       Date:  2020-01-24       Impact factor: 2.200

4.  Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease.

Authors:  R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Biochemistry       Date:  2005-12-20       Impact factor: 3.162

5.  A competition assay to identify amyloidogenesis inhibitors by monitoring the fluorescence emitted by the covalent attachment of a stilbene derivative to transthyretin.

Authors:  Sungwook Choi; Jeffery W Kelly
Journal:  Bioorg Med Chem       Date:  2010-12-30       Impact factor: 3.641

Review 6.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

Review 7.  The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

Authors:  Steven M Johnson; Stephen Connelly; Colleen Fearns; Evan T Powers; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

8.  The Endoplasmic Reticulum-associated Degradation of Transthyretin Variants Is Negatively Regulated by BiP in Mammalian Cells.

Authors:  Seiko Susuki; Takashi Sato; Masanori Miyata; Mamiko Momohara; Mary Ann Suico; Tsuyoshi Shuto; Yukio Ando; Hirofumi Kai
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

9.  Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.

Authors:  Satheesh K Palaninathan; Nilofar N Mohamedmohaideen; Elisabetta Orlandini; Gabriella Ortore; Susanna Nencetti; Annalina Lapucci; Armando Rossello; Joel S Freundlich; James C Sacchettini
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

10.  Mobile and cordless telephones, serum transthyretin and the blood-cerebrospinal fluid barrier: a cross-sectional study.

Authors:  Fredrik Söderqvist; Michael Carlberg; Lennart Hardell
Journal:  Environ Health       Date:  2009-04-21       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.